Literature DB >> 26622601

Minichromosome maintenance complex component 7 has an important role in the invasion of papillary urothelial neoplasia.

Bingxin Guan1, Xiaoying Wang1, Jingyan Yang1, Chengjun Zhou1, Yan Meng2.   

Abstract

The aims of the present study were to investigate the expression of minichromosome maintenance complex component 7 (MCM7) and determine its association with tumor proliferation and invasion in pathological tumor (pT)a and pT1 papillary urothelial neoplasia. The MCM7, MCM3 and Ki67 proteins were detected in 154 cases of urothelial neoplasia using immunohistochemical analysis. The expression of MCM7 significantly increased (P<0.001) as the pathological stage and grade progressed between inverted papilloma, papillary urothelial neoplasm of low malignant potential (PUNLMP), pTa tumor and pT1 tumor. However, no statistically significant difference in MCM7 staining was observed between low-grade pTa tumors and PUNLMP (P=0.2294). In contrast to MCM7, MCM3 was highly expressed in all stages of urothelial neoplasia, with no statistically significant differences observed between the tumor types (P=0.2993, 0.3885 and 0.8489 for pTa tumors, PUNLMP and inverted papiloma, respectively). Furthermore, MCM7 expression was elevated with increased tumor grade and was positively correlated with Ki67 expression (rs =0.9106, P<0.001). However, MCM3 expression was not correlated with MCM7 or Ki67 expression (rs =0.0734, P=0.3657 and rs =0.0638, P=0.4318, respectively). In conclusion, MCM7 overexpression may simultaneously promote tumor proliferation and invasion. Furthermore, it may be a reliable marker for the pathological differential diagnosis of pTa and pT1 papillary urothelial neoplasms; therefore, MCM7 expression may be used to predict tumor prognosis and behavior.

Entities:  

Keywords:  MCM3; minichromosome maintenance complex component (MCM)7; papillary neoplasm; urothelial neoplasia

Year:  2015        PMID: 26622601      PMCID: PMC4509410          DOI: 10.3892/ol.2015.3333

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  16 in total

1.  FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.

Authors:  Johanna M M van Oers; Peter J Wild; Maximilian Burger; Stefan Denzinger; Robert Stoehr; Elke Rosskopf; Ferdinand Hofstaedter; Ewout W Steyerberg; Monika Klinkhammer-Schalke; Ellen C Zwarthoff; Theodorus H van der Kwast; Arndt Hartmann
Journal:  Eur Urol       Date:  2007-01-12       Impact factor: 20.096

2.  MCM7 amplification and overexpression are associated with prostate cancer progression.

Authors:  B Ren; G Yu; G C Tseng; K Cieply; T Gavel; J Nelson; G Michalopoulos; Y P Yu; J-H Luo
Journal:  Oncogene       Date:  2006-02-16       Impact factor: 9.867

3.  Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.

Authors:  Simone Bertz; Wolfgang Otto; Stefan Denzinger; Wolf F Wieland; Maximilian Burger; Robert Stöhr; Stefan Link; Ferdinand Hofstädter; Arndt Hartmann
Journal:  Eur Urol       Date:  2012-05-19       Impact factor: 20.096

4.  Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.

Authors:  Jason M Shohet; M John Hicks; Sharon E Plon; Susan M Burlingame; Susan Stuart; Si-Yi Chen; Malcolm K Brenner; Jed G Nuchtern
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

5.  Mcm7, a subunit of the presumptive MCM helicase, modulates its own expression in conjunction with Mcm1.

Authors:  Michael J Fitch; Justin J Donato; Bik K Tye
Journal:  J Biol Chem       Date:  2003-05-07       Impact factor: 5.157

6.  FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder.

Authors:  Ashraf A Bakkar; Herve Wallerand; François Radvanyi; Jean-Baptiste Lahaye; Serge Pissard; Laure Lecerf; Jean Claude Kouyoumdjian; Claude C Abbou; Jean-Claude Pairon; Marie-Claude Jaurand; Jean-Paul Thiery; Dominique K Chopin; Sixtina Gil Diez de Medina
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

7.  Declining mortality from bladder cancer in Europe.

Authors:  Jacques Ferlay; Giorgia Randi; Cristina Bosetti; Fabio Levi; Eva Negri; Peter Boyle; Carlo La Vecchia
Journal:  BJU Int       Date:  2007-10-30       Impact factor: 5.588

8.  Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.

Authors:  Bas W G van Rhijn; André N Vis; Theo H van der Kwast; Wim J Kirkels; François Radvanyi; Engelbert C M Ooms; Dominique K Chopin; Egbert R Boevé; Adriaan C Jöbsis; Ellen C Zwarthoff
Journal:  J Clin Oncol       Date:  2003-05-15       Impact factor: 44.544

9.  Mammalian nuclei become licensed for DNA replication during late telophase.

Authors:  Daniela S Dimitrova; Tatyana A Prokhorova; J Julian Blow; Ivan T Todorov; David M Gilbert
Journal:  J Cell Sci       Date:  2002-01-01       Impact factor: 5.285

Review 10.  Initiating DNA synthesis: from recruiting to activating the MCM complex.

Authors:  M Lei; B K Tye
Journal:  J Cell Sci       Date:  2001-04       Impact factor: 5.285

View more
  4 in total

Review 1.  MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression.

Authors:  Zhikun Liu; Jie Li; Jun Chen; Qiaonan Shan; Haojiang Dai; Haiyang Xie; Lin Zhou; Xiao Xu; Shusen Zheng
Journal:  BMC Cancer       Date:  2018-02-20       Impact factor: 4.430

2.  Expression of Minichromosome Maintenance Proteins (MCM) and Cancer Prognosis: A meta-analysis.

Authors:  Kaihua Gou; Jingwei Liu; Xue Feng; Hao Li; Yuan Yuan; Chengzhong Xing
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207

Review 3.  MCMs in Cancer: Prognostic Potential and Mechanisms.

Authors:  Si Yu; Guanqun Wang; Yue Shi; Haifeng Xu; Yongchang Zheng; Yang Chen
Journal:  Anal Cell Pathol (Amst)       Date:  2020-02-03       Impact factor: 2.916

4.  Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development.

Authors:  Gurjeet Kaur; Shandra Devi Balasubramaniam; Yung Jen Lee; Venugopal Balakrishnan; Chern Ein Oon
Journal:  Asian Pac J Cancer Prev       Date:  2019-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.